MENU
SUPN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Supernus Pharmaceuticals (SUPN) Earnings Date & Reports

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company... Show more

A.I. Advisor
published Earnings

SUPN is expected to report earnings to fall 151.25% to 40 cents per share on March 03

Supernus Pharmaceuticals SUPN Stock Earnings Reports
Q4'25
Est.
$0.41
Q3'25
Missed
by $0.94
Q2'25
Missed
by $0.08
Q1'25
Missed
by $0.58
Q4'24
Missed
by $0.06
The last earnings report on November 04 showed earnings per share of -80 cents, missing the estimate of 14 cents. With 1.14M shares outstanding, the current market capitalization sits at 2.55B.
View a ticker or compare two or three
SUPN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SUPN showed earnings on November 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer for the treatment of central nervous system

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
9715 Key West Avenue
Phone
+1 301 838-2500
Employees
652
Web
https://www.supernus.com